期刊文献+

肺癌上皮-间质转变现象的研究进展 被引量:3

Research progress in epithelial-mesenchymal transition phenomenon in lung cancer
下载PDF
导出
摘要 近几年来对于恶性肿瘤上皮-间质转变(epithelial-mesenchymal transition,EMT)现象的研究成为了防治恶性肿瘤的研究热点。国内外的研究发现恶性肿瘤如卵巢癌、前列腺癌、胃癌等中EMT现象参与恶性肿瘤局部淋巴结及远处脏器的转移,并发现EMT现象中主要的分子蛋白及信号通路。对于死亡率最高的恶性肿瘤肺癌中EMT现象的研究也取得了一定的成果。本文对于肺癌EMT现象中相关诱导分子及信号通路等方面的研究成果作一综述,希望通过总结分析,明确以后的研究方向,进一步探索肺癌等恶性肿瘤的分子靶向治疗方式。 More researches focus on epithelial-mesenchymal transition (EMT) phenomenon in malignant tumor in recent years. These researches reveal that EMT phenomenon in several tumors such as ovary cancer, prostate cancer and gastric cancer is involved in local lymph nodes and remote organs metastasis. The relevant molecule proteins and signal pathways are also studied. Researches on EMT phenomenon in lung cancer also make a lot of progress. In this article, the research progress in relevant molecules and signal pathways in EMT in lung cancer was reviewed.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2009年第3期372-375,共4页 Fudan University Journal of Medical Sciences
关键词 肺癌 上皮-间质转变 信号通路 lung cancer epithelial-mesenchymal transition signal pathway
  • 相关文献

参考文献32

  • 1Pisters KM,Chevalier TL.Adjuvant chemotherapy in completely resected non-small-cell lung cancer[J].J Clin Oncol,2005,23(14):3 270-3 278.
  • 2Thiery JP.Epithelial-mesenchymal transitions in tumour progression[J].Nat Rev Cancer,2002,2(6):442-454.
  • 3Hugo H,Ackland ML,Blick T,et al.Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression[J].Journal Cell Physiol,2007,213:374-383.
  • 4Vallin J,Thuret R,Giacomello E,et al.Cloning and characterization of three Xenopus slug promotes reveal direct regulation by Lef/beta-catenin signaling[J].J Biol Chem,2001,276(32):30 350-30 358.
  • 5Huber MA,Kraut N,Beug H.Molecular requirements for epithelial-mesenchymal transition during tumor progression[J].Curr Opin Cell Biol,2005,17(5):548-558.
  • 6Thompson EW,Paik S,Brunner N,et al.Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines[J].J Cell Physiol,1992,150:534-544.
  • 7Lawrence M,Veveris-Lowe T,Whitbread A,et al.Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases[J].Cells Tissues Organs,2007,185:111-115.
  • 8Ray ME,Mehra R,Sandler HM,et al.E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes[J].J Urol,2006,176:1 409-1 414.
  • 9Katoh M.Epithelial-mesenchymal transition in gastric cancer (Review)[J].International Journal of Oncology,2005,27(6):1 677-1 683.
  • 10Neve RM,Chin K,Fridlyand J,et al.A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes[J].Cancer Cell,2006,10:515-527.

同被引文献69

  • 1Chamber AF,Matrisian LM.Changing views of matrix metalloproteinase in metastasis.Natl Cancer Inst,1997,89:1260-1265.
  • 2Person SL,Watson SA,Brown PD,et al.Matrix metalloproteinase.Br J Surg,1997,84:160-166.
  • 3Thomas P,Khokha R,Shepherd FA,et al.Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer.Pathol,2000,190(2):150-156.
  • 4Delebecq TJ.Porte H,Zerimech F,et al.Overexpression level of Stromelysin 3 is related to the lymph nodeinvolvement in non-sinail cell lung cancer.Clin Cancer Res,2000,6(3):1086-1092.
  • 5Clarke LE,Leitzel K,Smith J,et al.Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic,lung,and colon carcinomas detected by RT-PCR.Int J Oncol,2003,22(2):425-430.
  • 6Chakra M,Pujol JL,Lamy PJ,et al.Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.J Thorac Oncol,2008,3(10):1119-1126.
  • 7Leung DW,Cachianes G,Kuang WJ,et al.Vascular endothelial growth factor is a secreted angiogenic mitogen.Science,19989,246:1306-1309.
  • 8Neufeld G,Cohen T,Cengrinovitch S,et al.Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-KB activation in the mopoietic progenitor cells.J Inrmunol,1998,160(8):1224.
  • 9Neufeld G,Cohen T,Cengrinovitch S,et al.vascular endothelial growth factor(VEGF) and its receptors.FASEB J,1999,13(1):9-17.
  • 10Pujol JL,Breton JL,Gervais R,et al.Phase III double blind,placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy.Clin Oncol,2007,25(25):3945-3951.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部